MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

148.36 UNCHANGED
Delayed Quote Updated: 7:00 PM EST, Nov 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
European Commission Approves KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)
From Merck & Co., Inc.
Via Business Wire
News headline image
Forget COVID: Moderna Is Turning Into a Cancer Company -- and Wall Street Is Taking Notice ↗
This company made headlines with its coronavirus vaccine. 
Via The Motley Fool
Dow Jones Top Gainers in Today's Session: 3M Leads ↗
Via Chartmill
Topics Stocks
Dow Jones Top Gainers on Oct. 20, 2026: MMM, UNH, MRK Lead Session ↗
Via Chartmill
Topics Stocks
Merck (NYSE:MRK) Nears Breakout Setup With Strong Technical Ratings ↗
Via Chartmill
Merck & Co. (NYSE:MRK): A Quality Investing Case With Strong ROIC but Revenue Growth Concerns ↗
Via Chartmill
News headline image
2 High-Flying Dividend Stocks to Buy and Hold for a Decade ↗
They may just be getting started. 
Via The Motley Fool
Topics Intellectual Property
News headline image
The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winning ↗
AI-driven "biointelligence" is reshaping healthcare investing, with Guardant Health, Illumina, Eli Lilly and Moderna emerging as key stocks as data-driven testing, sequencing and therapies compound. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
If a Stock Market Crash Is Coming, History Says These 3 ETFs Are the Smartest Buys ↗
These funds can help you weather any storm that might be on the way. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
Novo Nordisk and Eli Lilly Just Got Some Fantastic News ↗
A new government-funded study found that GLP-1 drugs slow the aging process in mice. 
Via The Motley Fool
Discover which dow jones stocks are making waves on Thursday. ↗
Via Chartmill
Stock Market Today: Hot Inflation and a Neocloud Shakeout Sink the Nasdaq ↗
Via Chartmill
Topics Economy
Discover which dow jones stocks are making waves on Wednesday. ↗
Via Chartmill
Top S&P500 movers in Wednesday's session ↗
Via Chartmill
These dow jones stocks are moving in today's session ↗
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
Discover which dow jones stocks are making waves on Tuesday. ↗
Via Chartmill
News headline image
Paul J. Diaz Elected to Merck & Co., Inc., Rahway, N.J., USA Board of Directors
From Merck & Co., Inc.
Via Business Wire
News headline image
Merck Showcases First-Time Pivotal Phase 3 Results From Oncology Pipeline and Continued Innovative Potential of Existing Portfolio at ESMO 2026
From Merck & Co., Inc.
Via Business Wire
News headline image
Moderna Is Now Worth More Than 3X as Much as BioNTech. Which Biotech Stock Is the Smarter Pick? ↗
Is bigger always better? Not necessarily. 
Via The Motley Fool
Uncover the latest developments among dow jones stocks in today's session. ↗
Via Chartmill
News headline image
These 3 Stocks Are Crushing the "Magnificent Seven" This Year -- Are They Still Buys? ↗
Forget the "Magnificent Seven" in favor of the "Tremendous Three"? 
Via The Motley Fool
News headline image
3 Profitable Stocks We Approach with Caution
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
News headline image
Moderna Now Trades 61% Above Wall Street's Average Price Target. Should You Sell? ↗
After a few years of stagnation, this stock is soaring. 
Via The Motley Fool
News headline image
Merck Presents One-Year Results from the Pivotal Phase 2b/3 BRUNELLO Study Evaluating Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, in Adults with Diabetic Macular Edema at AAO 2026
From Merck & Co., Inc.
Via Business Wire
News headline image
Why Moderna Stock Surged Today ↗
The biotech could play a significant role in a national effort to combat cancer. 
Via The Motley Fool
Topics Artificial Intelligence
Friday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
Top dow jones movers in Friday's session ↗
Via Chartmill
News headline image
2 Growth Stocks to Buy in October ↗
Grail and Veeva Systems could be well insulated from near-term headwinds. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story